drugset / Trial / NCT05823363

Vaginal Cuff Infiltration With Liposomal Bupivacaine for Pain Relief: A Double Blind, Randomized Controlled Trial

NCT05823363 ↗

Phase 4 Withdrawn Olivia Sher
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal is to find out if Exparel (liposomal bupivacaine) given as an injection decreases pain score if given into the vaginal cuff right before starting the minimally invasive (robotic-assisted or laparoscopic) total hysterectomy in patients scheduled for benign indication? Participants will write down 1. pain score at various intervals 2. pain medication used Treatment patients will receive 1)intervention arm will receive Exparel mixed with bupivicaine 2)control arm will receive bupivicaine only

Timeline

Start
2024-09-09
Primary completion
2024-09-09
Completion
2024-09-09

Outcome

Outcome not reported

Stopped: “PI left institution”

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 10 ml Other
Subject Bupivacaine Other / unclassified 20 ml Other

Indications

No indication recorded.